These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 37202020)

  • 1. Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures.
    Pichon-Riviere A; Drummond M; Palacios A; Garcia-Marti S; Augustovski F
    Lancet Glob Health; 2023 Jun; 11(6):e833-e842. PubMed ID: 37202020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research.
    Woods B; Revill P; Sculpher M; Claxton K
    Value Health; 2016 Dec; 19(8):929-935. PubMed ID: 27987642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review.
    Cameron D; Ubels J; Norström F
    Glob Health Action; 2018; 11(1):1447828. PubMed ID: 29564962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating a cost-effectiveness threshold for health care decision-making in South Africa.
    Edoka IP; Stacey NK
    Health Policy Plan; 2020 Jun; 35(5):546-555. PubMed ID: 32125375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guide posts for investment in primary health care and projected resource needs in 67 low-income and middle-income countries: a modelling study.
    Stenberg K; Hanssen O; Bertram M; Brindley C; Meshreky A; Barkley S; Tan-Torres Edejer T
    Lancet Glob Health; 2019 Nov; 7(11):e1500-e1510. PubMed ID: 31564629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review.
    Kazibwe J; Gheorghe A; Wilson D; Ruiz F; Chalkidou K; Chi YL
    Value Health; 2022 Mar; 25(3):385-389. PubMed ID: 35227450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the range of incremental cost-effectiveness thresholds for healthcare based on willingness to pay and GDP per capita: A systematic review.
    Iino H; Hashiguchi M; Hori S
    PLoS One; 2022; 17(4):e0266934. PubMed ID: 35421181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflecting the Health Opportunity Costs of Funding Decisions Within Value Frameworks: Initial Estimates and the Need for Further Research.
    Ochalek J; Lomas J
    Clin Ther; 2020 Jan; 42(1):44-59.e2. PubMed ID: 31955967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANALYSIS OF TRENDS IN LIFE EXPECTANCIES AND PER CAPITA GROSS DOMESTIC PRODUCT AS WELL AS PHARMACEUTICAL AND NON-PHARMACEUTICAL HEALTHCARE EXPENDITURES.
    Hermanowski T; Bystrov V; Staszewska-Bystrova A; Szafraniec-Buryło SI; Rabczenko D; Kolasa K; Orlewska E
    Acta Pol Pharm; 2015; 72(5):1045-50. PubMed ID: 26665412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding and improving the one and three times GDP per capita cost-effectiveness thresholds.
    Robinson LA; Hammitt JK; Chang AY; Resch S
    Health Policy Plan; 2017 Feb; 32(1):141-145. PubMed ID: 27452949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative value-based pricing of an Ebola vaccine in resource-constrained countries based on cost-effectiveness analysis.
    Obeng-Kusi M; Erstad B; Roe DJ; Abraham I
    J Med Econ; 2022; 25(1):894-902. PubMed ID: 35748085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds.
    Daroudi R; Akbari Sari A; Nahvijou A; Faramarzi A
    Cost Eff Resour Alloc; 2021 Feb; 19(1):7. PubMed ID: 33541364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effective outlays for better health outcomes.
    Shmueli A
    World Health Forum; 1995; 16(3):287-92. PubMed ID: 7546177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Framework for developing cost-effectiveness analysis threshold: the case of Egypt.
    Fasseeh AN; Korra N; Elezbawy B; Sedrak AS; Gamal M; Eldessouki R; Eldebeiky M; George M; Seyam A; Abourawash A; Khalifa AY; Shaheen M; Abaza S; Kaló Z
    J Egypt Public Health Assoc; 2024 Jun; 99(1):12. PubMed ID: 38825614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informing Global Cost-Effectiveness Thresholds Using Country Investment Decisions: Human Papillomavirus Vaccine Introductions in 2006-2018.
    Jit M
    Value Health; 2021 Jan; 24(1):61-66. PubMed ID: 33431154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost effectiveness of treating paediatric cancer in low-income and middle-income countries: a case-study approach using acute lymphocytic leukaemia in Brazil and Burkitt lymphoma in Malawi.
    Bhakta N; Martiniuk AL; Gupta S; Howard SC
    Arch Dis Child; 2013 Feb; 98(2):155-60. PubMed ID: 23201550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmet needs in countries participating in the undiagnosed diseases network international: an international survey considering national health care and economic indicators.
    Sciascia S; Roccatello D; Salvatore M; Carta C; Cellai LL; Ferrari G; Lumaka A; Groft S; Alanay Y; Azam M; Baynam G; Cederroth H; Cutiongco-de la Paz EM; Dissanayake VHW; Giugliani R; Gonzaga-Jauregui C; Hettiarachchi D; Kvlividze O; Landoure G; Makay P; Melegh B; Ozbek U; Puri RD; Romero VI; Scaria V; Jamuar SS; Shotelersuk V; Gahl WA; Wiafe SA; Bodamer O; Posada M; Taruscio D
    Front Public Health; 2023; 11():1248260. PubMed ID: 37822540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financing transformative health systems towards achievement of the health Sustainable Development Goals: a model for projected resource needs in 67 low-income and middle-income countries.
    Stenberg K; Hanssen O; Edejer TT; Bertram M; Brindley C; Meshreky A; Rosen JE; Stover J; Verboom P; Sanders R; Soucat A
    Lancet Glob Health; 2017 Sep; 5(9):e875-e887. PubMed ID: 28728918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International health care spending.
    Schieber GJ; Puollier JP
    Health Aff (Millwood); 1986; 5(3):111-22. PubMed ID: 3098657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating cost-effectiveness thresholds under a managed healthcare system: experiences from Colombia.
    Espinosa O; Rodríguez-Lesmes P; Orozco L; Ávila D; Enríquez H; Romano G; Ceballos M
    Health Policy Plan; 2022 Mar; 37(3):359-368. PubMed ID: 34875689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.